Onconova Therapeutics, Inc. ( ONTX ) was a big mover last session with its shares rising just over 14% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend of the company as the stock is has gained over 22% in the past five trading sessions.
This clinical-stage biopharmaceutical company has seen no estimate revision in the last 7 days. The Zacks Consensus Estimate hasn't been in trend either. Yesterday's price action is encouraging though, so make sure to keep a close watch on this firm in the near future.
Onconova Therapeutics currently has a Zacks Rank #4 (Sell) while its Earnings ESP is negative.
Investors interested in the Med-Drugs industry may consider better-ranked stocks like Aeolus Pharmaceuticals Inc. ( AOLS ), Ariad Pharmaceuticals Inc. ( ARIA ) and Ohr Pharmaceutical, Inc. ( OHRP ). All the three stocks sport a Zacks Rank #2 (Buy).